Confounders and co-interventions identified in non-randomized studies of interventions.
Acute coronary syndrome (ACS)
Bleeding
Clinical practice research datalink (CPRD)
Confounders
Coronary artery bypass grafting (CABG)
Dual antiplatelet therapy (DAPT)
Hospital episode statistics (HES)
Non-randomized studies of interventions (NRSI)
Percutaneous coronary intervention (PCI)
Target trial
Journal
Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
16
10
2021
revised:
14
02
2022
accepted:
23
03
2022
pubmed:
30
3
2022
medline:
27
10
2022
entrez:
29
3
2022
Statut:
ppublish
Résumé
To identify potential confounders and co-interventions systematically to optimise control of confounding for three non-randomized studies of interventions (NRSI) designed to quantify bleeding in populations exposed to different dual antiplatelet therapy (DAPT). Systematic review, interviews, and surveys with clinicians. We searched Ovid Medline, Ovid Embase, and the Cochrane Library to identify randomized-controlled trials and cohort studies of DAPT interventions. Two researchers independently screened citations, identified eligible studies and extracted data. We conducted individual semi-structured interviews with six cardiologists and six cardiac surgeons to elicit factors clinicians consider when they prescribe DAPT. We administered two online surveys for members of professional cardiology and cardiac surgery organisations. We screened 2,544 records, identified 322 eligible studies, and extracted data from 47. We identified 10 co-interventions and 70 potential confounders: review 31 (91%); interviews 19 (56%); surveys 31 (91%). 16/34 (47%) were identified by all three methods while, 3/34 (9%) were picked up by one method only. The review identified the majority of factors, but the interviews identified hard-to-measure factors such as perceived patient adherence and local prescribing culture. The methods could, in principle, be widely applied when designing or reviewing non-randomized studies of interventions (NRSI).
Identifiants
pubmed: 35346782
pii: S0895-4356(22)00079-8
doi: 10.1016/j.jclinepi.2022.03.018
pii:
doi:
Substances chimiques
Platelet Aggregation Inhibitors
0
Types de publication
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
115-123Subventions
Organisme : Medical Research Council
ID : MR/M025209/1
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom
Informations de copyright
Copyright © 2022. Published by Elsevier Inc.